NervGen Pharma (NGENF) Q3 2025 Earnings

27AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.1
-0.08
-0.06
-0.04

Details

Expected EPS
-0.0550875
Actual EPS
-0.095485
Surprise EPS
-0.04
Surprise Percent
+73.33%

Description

NervGen Pharma (NGENF) has reported earnings of -0.095485 per share for Q3 2025.

0 Comments

Share your thoughts